BioDelivery Sciences Announces Further Improved Insurance Coverage for BELBUCA®

    NEXT STORY
    CorMedix Receives Encouraging FDA Feedback on Neutrolin® LOCK-IT-100 Data
    PREV STORY
    Inovalon Reaches Milestone and Achieves Integration With Epic
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Summit Therapeutics plc : 1st Quarter Results

    Summit Therapeutics plc('Summit', the 'Company' or the 'Group') Summit Therapeutics Reports Financial Results for ...

    author_avatar
    NASDAQ Market News

    BioCorRx’s Subsidiary, BioCorRx Pharmaceuticals, to Exhibit at ASAM 50th Annual Conference in Orlando, Florida

    author_avatar
    NASDAQ Market News

    Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

    BOSTON, Oct. 02, 2017 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company ...

    author_avatar
    NASDAQ Market News